Corten Capital, Ampersand Capital Partners acquire Beacon Intelligence from Hanson Wade Group

Corten Capital completed the acquisition of Beacon Intelligence from Hanson Wade Group, backed by Graphite Capital, to accelerate growth in life sciences R&D intelligence.
Ampersand Management LLC invested as a minority co-investor alongside majority owner Corten Capital; Beacon will operate as an independent company.
Beacon, founded in 2015, serves more than 300 customers globally, including 24 of the 30 largest pharmaceutical companies.
David Anderson of Ampersand Capital Partners will join Beacon’s board; CEO Rob Poolman continues to lead the business, chaired by Sati S. Sian.
Corten Capital II closed in March 2024 with EUR 680 million; Beacon is the fund’s third investment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ampersand Management LLC published the original content used to generate this news brief on June 30, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.